Bank of America Securities Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a ...
Vertex Pharmaceuticals price target raised to $540 from $522 at BofA
BofA analyst Tazeen Ahmad raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $540 from $522 and keeps a Buy rating on the ...
MarketWatch20h
Crude Oil Mar 2025
2-Year U.S. Treasury Note Continuous Contract $102.738-0.074-0.07% 5-Year U.S. Treasury Note Continuous Contract $106.359-0.031-0.03% 10-Year U.S. Treasury Note Continuous Contract $108.906 0.063 ...
MarketWatch21h
RBOB Gasoline (NYM $/gal) Front Month
2-Year U.S. Treasury Note Continuous Contract $102.879-0.016-0.02% 5-Year U.S. Treasury Note Continuous Contract $106.539-0.078-0.07% 10-Year U.S. Treasury Note Continuous Contract $109.031-0.203 ...